84-4352-90 Parkin (PARK2, PRKN, E3 ubiquitin-protein ligase parkin, Parkinson juvenile disease protein 2, Parkinson disease protein 2) 100ul 327529

※お見積書はカートで印刷できます

冷凍

特徴

  • Functions within a multiprotein E3 ubiquitin ligase complex, catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins, such as BCL2, SYT11, CCNE1, GPR37, STUB1, a 22kD O-linked glycosylated isoform ofSNCAIP, SEPT5, ZNF746 and AIMP2.
  • Mediates monoubiquitination as well as 'Lys-48'-linked and 'Lys-63'-linked polyubiquitination of substrates depending on the context.
  • Participates in the removal and/or detoxification of abnormally folded or damaged protein by mediating 'Lys-63'-linked polyubiquitination of misfolded proteins such as PARK7: 'Lys-63'-linked polyubiquitinated misfolded proteins are then recognized by HDAC6, leading to their recruitment to aggresomes, followed by degradation.
  • Mediates 'Lys-63'-linked polyubiquitination of SNCAIP, possibly playing a role in Lewy-body formation.
  • Mediates monoubiquitination of BCL2, thereby acting as a positive regulator of autophagy.
  • Promotes the autophagic degradation of dysfunctional depolarized mitochondria (mitophagy), potentially by the ubiquitination of mitochondrial proteins.
  • Mediates 'Lys-48'-linked polyubiquitination of ZNF746, followed by degradation of ZNF746 by the proteasome; possibly playing a role in the regulation of neuron death.
  • Limits the production of reactive oxygen species (ROS).
  • Regulates cyclin-E during neuronal apoptosis.
  • In collaboration with CHPF isoform 2, may enhance cell viability and protect cells from oxidative stress.
  • Independently of its ubiquitin ligase activity, protects from apoptosis by the transcriptional repression of p53/TP53.
  • May protect neurons against alpha synuclein toxicity, proteasomal dysfunction, GPR37 accumulation, and kainate-induced excitotoxicity.
  • May play a role in controlling neurotransmitter trafficking at the presynaptic terminal and in calcium-dependent exocytosis.
  • May represent a tumor suppressor gene.Fang Yang, J.
  • Biol.
  • Chem., Apr 2005; 280: 17154 - 17162.
  • Yukiko Kuroda, Hum.
  • Mol.
  • Genet., Mar 2006; 15: 883 - 895.
  • Iris H.
  • Henn, J.
  • Neurosci., Feb 2007; 27: 1868 - 1878.
  • Monica Joch, Mol.
  • Biol.
  • Cell, Jun 2007; 10.1091/mbc.E05-11-1027.
  • Applications:Suitable for use in Western Blot and Immunohistochemistry.
  • Other applications not tested.
  • Recommended Dilution:Western Blot: 1:500-1:3000Immunohistochemistry: 1:50-1:100Optimal dilutions to be determined by the researcher.
  • Storage and Stability:May be stored at 4°C for short-term only.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • Aliquots are stable for 12 months after receipt.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

  • Size:100ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by immunoaffinity chromatography.
  • Form:Supplied as a liquid in PBS, pH 7.4, 150mM sodium chloride, 0.02% sodium azide, 50% glycerol.
  • Specificity:Species Crossreactivity: mouse and rat
  • Isotype:IgG
  • Calc Applications Abbrev:IHC WB
  • Calc Crossreactivity:Hu Mo Rt
  • Immunogen:Synthetic peptide corresponding to human Parkin.
  • Shelf Life:1year
  • Swiss Prot Number:O60260
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-4352-90
型番
327529
入り数
1個
標準価格
129,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る